A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia
NCT00882713
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
202
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia
Interventions
DRUG:
methoxy polyethylene glycol-epoetin beta [Mircera]
Sponsor
Hoffmann-La Roche